Drug resistance is estimated to affect about a third of individuals with epilepsy, but its
prevalence differs in relation to the epilepsy syndrome, the cause of epilepsy, and other …

There are currently> 51 million people with epilepsy (PWE) in the world and every year> 4.9
million people develop new-onset epilepsy. The cornerstone of treatment in PWE is drug …

Background The evaluation and management of first-time seizure-like events in children can
be difficult because these episodes are not always directly observed and might be epileptic …

Despite progress in the development of anti‐seizure medications (ASMs), one third of
people with epilepsy have drug‐resistant epilepsy (DRE). The working definition of DRE …

The pharmacological treatment of epilepsy entails several critical decisions that need to be
based on an individual careful risk–benefit analysis. These include when to initiate treatment …

Objective Epilepsy with generalized tonic–clonic seizures alone (GTCA) is a common but
poorly characterized idiopathic generalized epilepsy (IGE) syndrome. Hence, we …

Importance After the recent limitations to prescribing valproate, many studies have
highlighted the challenging management of female patients of reproductive age with …

Objective The purpose of the current endeavor was to evaluate the feasibility of using easily
accessible and applicable clinical information (based on history taking and physical …

Although a striking female preponderance has been consistently reported in epilepsy with
eyelid myoclonia (EEM), no study has specifically explored the variability of clinical …

Good to excellent predictive models are now available to guide medical and surgical
epilepsy decision-making with nomograms offering individualized predictions and user …